Trial Profile
Efficacy and tolerability of beclometasone/formoterol and salmeterol/fluticasone propionate in Taiwanese patients with inadequately controlled moderate to severe asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2019
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Orient Europharma
- 29 Oct 2013 New trial record
- 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.